PCN54 EFFICACY AND SAFETY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED, ADVANCED STAGE MYCOSIS FUNGOIDES AND SÉZARY SYNDROME PATIENTS: A POST-HOC ANALYSIS OF THE MAVORIC STUDY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.251
https://www.valueinhealthjournal.com/article/S1098-3015(19)32629-4/fulltext
Title :
PCN54 EFFICACY AND SAFETY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED, ADVANCED STAGE MYCOSIS FUNGOIDES AND SÉZARY SYNDROME PATIENTS: A POST-HOC ANALYSIS OF THE MAVORIC STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32629-4&doi=10.1016/j.jval.2019.09.251
First page :
Section Title :
Open access? :
No
Section Order :
10195